Avricore Health (AVCRF) Amortization of Deferred Charges (2020 - 2021)

Avricore Health (AVCRF) posted quarterly Amortization of Deferred Charges of $30369.8 for Q1 2021, up 235.72% year-over-year from $9046.2 in Q1 2020, and down 13.79% quarter-over-quarter from $35226.2 in Q4 2020.

Avricore Health (AVCRF) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends

Avricore Health (AVCRF) has reported Amortization of Deferred Charges for 2 consecutive years, with $30369.8 the latest figure, recorded in Q1 2021.

  • In Q1 2021, Amortization of Deferred Charges rose 235.72% year-over-year to $30369.8; the TTM figure through Dec 2021 stood at $30369.8 (down 71.59% YoY), while the FY2021 annual figure was $30671.8, down 71.56% from the prior year.
  • Amortization of Deferred Charges declined to $30369.8 in Q1 2021 per AVCRF's latest filing, from $35226.2 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $59601.0 in Q2 2020 and bottomed at -$22376.8 in Q1 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 Avricore Health 3.04 Mn 3.01 Mn -6,202.70

Historic Data

Download Data
DateValue
Mar 31, 2021 30,369.83
Mar 31, 2021 30,369.83
Dec 31, 2020 35,226.22
Dec 31, 2020 35,226.22
Sep 30, 2020 34,461.71
Sep 30, 2020 34,461.71
Jun 30, 2020 59,601.02
Jun 30, 2020 59,601.02
Mar 31, 2020 -22,376.84
Mar 31, 2020 -22,376.84